Search Results - "Zinych, O.V."

Study of the relationships of polymorphisms of the folate cycle genes with the levels of homocysteine and folic acid as risk factors of cardiovascular disorders in the post-covid period by Shuprovych, A.A., Zinych, O.V., Kushnareva, N.M., Komisarenko, K.P.

“…Enzymes of the folate cycle participate in the process of remethylation of homocysteine (HC) to methionine, where folates are coenzymes for methyl transfer…”
Get full text

Product of metabolic activity of intestinal microbium trimethylamine-N-oxide (TMAO)— biomarker of progression of atherosclerosis-copy in the heart of the heart by Shyshkan-Shyshova, К.О., Zinych, O.V.

“…The literature data on the importance of intestinal microbiota as an endocrine organ— producer of biologically active metabolites, which perform key functions…”
Get full text

Cardiometabolic characteristics of type 2 diabetes patients depending on obesity phenotypes by Prybyla, O.V., Zinych, O.V., Kushnareva, N.M., Kovalchuk, A.V., Shyshkan-Shyshova, K.O.

“…Background. The problem of studying the causes and mechanisms of metabolic disorders in metabolic syndrome and type 2 diabetes mellitus (T2DM) is one of the…”
Get full text

The role of epigenetic modifications in the formation of heterogeneous phenotypes in diabetes mellitus (a literature review) by Zinych, O.V., Shuprovych, A.A., Trofymenko, O.M., Komisarenko, K.P.

“…This review article provides a summary and update on the role of epigenetic mechanisms in predisposition and progression of diabetes, analyzes the data…”
Get full text

The effects of incretin mimetics on the level of the microbial metabolite trimethylamine-N-oxide, a marker of cardiovascular risk in type 2 diabetic patients by Shyshkan-Shyshova, K.O., Zinych, O.V., Кushnareva, N.M., Кovalchuk, A.V., Prybyla, О.V.

“…Background. The purpose was to investigate the effect of therapy with glucagon-like peptide-1 receptor agonists (GLP-1ra) on the serum concentration of…”
Get full text

The indicator of osteogenesis is a potential marker of the risk of cardiovascular diseases in patients with type 2 diabetes mellitus by Кovalchuk, A.V., Zinych, O.V., Kushnarоva, N.M., Kovalchuk, V.M., Prybyla, O.V., Shyshkan-Shyshova, K.O.

“…Background. An increase in mortality due to cardiovascular diseases in patients with diabetes mellitus necessitates the search for effective prevention and…”
Get full text

Functional activity of the adrenal glands in type 2 diabetes patients with different hormonal and metabolic phenotypes by Prybyla, O.V., Zinych, O.V., Kushnarova, N.M., Kovalchuk, A.V., Shyshkan-Shyshova, K.O.

“…Background. Clinical trials showed a number of additional phenotypes of metabolic syndrome. All of them differ in the type of metabolic disorders and the…”
Get full text

Study of the association of polymorphisms of the folate cycle enzyme gene with the degree of cognitive and affective disorders in patients in the post-covid period by Shuprovych, A.A., Zinych, O.V., Kushnareva, N.M., Trofymenko, O.M., Komisarenko, K.P.

“…Recently, molecular genetic studies have become widespread, and demonstrated the importance of DNA and histone methylation processes in the epigenetic…”
Get full text

Decrease in the efficacy of glucagon-like peptide-1 receptor agonists: what is the reason? by Kushnarova, N.M., Zinych, O.V., Korpavchev, V.V., Kovalchuk, A.V., Prybyla, O.V., Shyshkan-Shishova, K.O.

“…The review deals with the drugs of a group of glucagon-like peptide-1 receptors agonists (GLP-1RA) the action of which is based on the incretin effect. In…”
Get full text

Effect of probiotics and incretine mimeticss on the levels of glucagon-like peptide-1 in blood serum of patients with type 2 diabetes mellitus by Shyshkan-Shyshova, K.A., Zinych, O.V., Kushnareva, N.M., Кovalchuk, A.V., Prybyla, O.V.

“…Background. Type 2 diabetes mellitus is characterized by a violation of the incretin effect, in particular a decrease in the secretion of glucagon-like…”
Get full text

В унісон із світовими тенденціями: клінічні аспекти застосування ліраглутиду в комбінації з інсуліном у пацієнтів із цукровим діабетом (огляд літератури і клінічні спостереження) by Korpacheva-Zinych, O.V., Kushnariova, N.M., Kovalchuk, A.V., Prybila, O.V., Shyshkan-Shyshova, K.O., Huryna, N.M., Korpachev, V.V.

“…Надано огляд літератури з питань терапії цукрового діабету 1-го і 2-го типу на основі інкретинового ефекту, про механізми дії, переваги й обмеження нового…”
Get full text

Инсуман® Базал, Инсуман® Комб, Инсуман® Рапид в одноразовых шприц-ручках СолоСтар® — единственные в Украине человеческие инсулины в одноразовых шприц-ручках СолоСтар by Korpacheva-Zinych, O.V., Gurina, N.M., Korpachev, V.V.

“…Статья посвящена теме инсулинотерапии у больных сахарным диабетом. Дана подробная характеристика некоторых препаратов инсулина…”
Get full text

In Tune with the World Trends: Clinical Aspects of Liraglutide Use in Combination with Insulin in Patients with Diabetes Mellitus (Literature Review and Clinical Observations) by O.V. Korpacheva-Zinych, N.M. Kushnariova, A.V. Kovalchuk, O.V. Prybila, K.O. Shyshkan-Shyshova, N.M. Huryna, V.V. Korpachev

“…There is presented a review of the literature on the treatment of diabetes mellitus type 1 and 2 based on incretin effect, the mechanisms of action, advantages…”
Get full text

Insuman® Basal, Insuman® Comb, Insuman® Rapid in SoloStar® Disposable Pens — the Only Human Insulins in SoloStar® Disposable Pens in Ukraine by O.V. Korpacheva-Zinych, N.M. Gurina, V.V. Korpachev

“…The article deals with insulin therapy in patients with diabetes mellitus. Detailed characteristic of some insulin preparations is provided…”
Get full text